Freeline Therapeutics Company
Freeline Therapeutics works with systematic AAV-based gene therapy, which is a type of virus programmed to direct genes where they need to go. Their pipeline focuses on treating inherited diseases, such as Haemophilia, Fabry Disease, and Gaucher Disease.
.png)
.png)
(Reupload).png)
.png)
(Reupload).png)
Technology:
P4 Medicine
Industry:
Gene Therapy
Headquarters:
Stevenage, Herefordshire, United Kingdom
Founded Date:
2015
Employees Number:
11-50
Funding Status:
Early Stage Venture
Investors Number:
9
Total Funding:
$276M
Estimated Revenue:
$1M to $10M
Last Funding Type:
Series C
Register and Claim Ownership